• Measuring Drug Response Beyond Viability

  2026-08-10

  Hannah Schwartz’s dissertation separates relative viability from fractional viability to clarify how cancer drugs inhibit proliferation and induce cell death. Its central implication is methodological: in vitro drug-response studies should treat growth suppression, killing, and response timing as related but nonidentical measurements.

• CHIR 99021 Trihydrochloride in Organoid Design

  2026-08-09

  CHIR 99021 trihydrochloride is a selective GSK-3 inhibitor for dissecting stem-cell state, Wnt-linked signaling, and glucose metabolism. This guide connects its molecular pharmacology with tunable intestinal organoid design and endpoint-aware assay planning.

• Resiquimod (R-848): From TLR Signals to Assays

  2026-08-08

  Resiquimod (R-848) is a dual TLR7/8 agonist that links innate immune response modulation with spatially controlled tumor-ablation research. This guide focuses on how to design, control, and interpret assays built around its timing, localization, and immune readouts.

• PD 0332991: A Cell-State Lens on Resistance

  2026-08-07

  PD 0332991 and Palbociclib HCl offer a selective way to interrogate CDK4/6–Rb–E2F control of proliferation. This article translates cisplatin-resistance findings into a resistance-aware assay framework that separates cytostasis, apoptosis, and tumor growth suppression.

• Anlotinib Hydrochloride: Applied Workflows for Multi-Target

  2026-08-07

  Anlotinib hydrochloride is a next-generation multi-target tyrosine kinase inhibitor with superior potency and selectivity for angiogenesis and tumor biology research. This guide translates reference breakthroughs and protocol data into actionable workflows, troubleshooting steps, and strategic insights, empowering cancer researchers to maximize reproducibility and discovery impact.

• Lipo3K Transfection Reagent: Enabling Next-Gen Nucleic Acid

  2026-08-06

  Discover how Lipo3K Transfection Reagent empowers high-efficiency nucleic acid delivery—even in difficult-to-transfect cells—while advancing assay design for emerging nucleic acid therapeutics. Explore its unique mechanism, protocol nuances, and insights from recent stimulus-responsive oligonucleotide research.

• Efficient Synthesis of Deuterium-Labeled Degarelix Acetate

  2026-08-06

  This study presents a streamlined 13-step protocol for synthesizing deuterium-labeled degarelix acetate, a potent GnRH receptor antagonist. The method enables reliable isotope incorporation, facilitating advanced pharmacokinetic and metabolic studies relevant to androgen-related diseases.

• EdU Flow Cytometry Assay Kits (Cy5): Beyond S-Phase Detectio

  2026-08-05

  Discover how EdU Flow Cytometry Assay Kits (Cy5) enable advanced, artifact-free analysis of cell proliferation, with unique insights into m7G-regulated cell cycle control. Learn why this CuAAC-based technology is essential for precise DNA synthesis detection in modern research.

• Fluorescein TSA Fluorescence System Kit: Reliable Signal Amp

  2026-08-05

  This article addresses real-world laboratory challenges in biomolecule detection using the Fluorescein TSA Fluorescence System Kit (SKU K1050). Through scenario-driven analysis, it demonstrates how this kit enhances sensitivity and reproducibility in IHC, ICC, and ISH workflows, supporting robust, data-backed experimental outcomes.

• Notch Inhibition Boosts Immunotherapy in Triple-Negative Bre

  2026-08-04

  Shen et al. demonstrated that targeted inhibition of the Notch pathway can reprogram the tumor immune microenvironment in triple-negative breast cancer (TNBC), enhancing the efficacy of immune checkpoint blockade (ICB) and reducing metastasis. These results highlight the therapeutic potential of combining Notch pathway inhibitors with immunotherapy in aggressive breast cancer subtypes.

• SNAI1 Drives EMT and Stemness via PIK3R2/p-EphA2 in Thymic T

  2026-08-04

  This study identifies SNAI1 as a central regulator of epithelial-mesenchymal transition (EMT) and cancer stem cell-like properties in thymic epithelial tumors (TETs), acting through the PIK3R2/p-EphA2 axis. Multi-omics and functional analyses reveal novel mechanistic insights and potential therapeutic targets for these rare malignancies.

• EdU Flow Cytometry Assay Kits (Cy5): Practical Workflow Guid

  2026-08-03

  The EdU Flow Cytometry Assay Kits (Cy5) offer a robust solution for quantifying cell proliferation via direct S-phase DNA synthesis detection, minimizing sample loss and background compared to traditional BrdU-based methods. This kit is ideal for research applications needing precise cell cycle analysis, provided users follow best practices for flow cytometry and avoid incompatible sample types, such as highly autofluorescent cells.

• Novobiocin: Antibacterial and Antiparasitic Mechanisms & Lim

  2026-08-03

  Novobiocin is an aminocoumarin antibiotic with potent antibacterial, antiparasitic, and antiviral activity. It acts primarily by inhibiting bacterial DNA gyrase and Hsp90, affecting DNA replication and protein folding. Evidence supports its synergy with lactoferrin and its relevance for resistance research.

• Glucocorticoids and IL-7R/BCL-2 Axis Drive Steroid Resistanc

  2026-08-02

  This study uncovers a paradoxical mechanism by which glucocorticoids induce resistance in T cell acute lymphoblastic leukemia (T-ALL) through upregulation of the IL-7 receptor and BCL-2. These findings highlight a reversible, intrinsic pathway of steroid resistance, reshaping approaches to apoptosis assays and targeted therapy in hematologic malignancies.

• Central AT1R Deficiency Mitigates Renal Fibrosis via SNS Mod

  2026-08-01

  Wan et al. (2024) reveal that angiotensin II type 1a receptor (AT1R) signaling in the hypothalamic paraventricular nucleus (PVN) amplifies sympathetic nerve activity and drives renal fibrosis following nephrotoxic injury. By dissecting the PVN–RVLM pathway in a mouse FA-CKD model, this study provides mechanistic clarity on brain–kidney crosstalk and identifies central AT1R as a potential therapeutic target.

8075 records 9/539 page Previous Next First page 上5页 678910 下5页 Last page